title: Graft failure and severe autoimmune haemolysis following fludarabine-based reduced-intensity matched unrelated donor bone marrow transplantation for severe aplastic anaemia: salvage by second transplant with conventional dose conditioning.
authors.forename: R
authors.initials: R
authors.lastname: Cutting
authors.forename: Y
authors.initials: Y
authors.lastname: Ezaydi
authors.forename: D
authors.initials: D
authors.lastname: Edbrooke
authors.forename: K
authors.initials: K
authors.lastname: El-Ghariani
authors.forename: R
authors.initials: R
authors.lastname: Stamps
authors.forename: J A
authors.initials: JA
authors.lastname: Snowden
mesh_terms: D000293:Adolescent; D000741:Anemia, Aplastic / Q000150:complications / Q000628:therapy*; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced / Q000209:etiology* / Q000628:therapy; D016026:Bone Marrow Transplantation / Q000009:adverse effects* / Q000379:methods; D005260:Female; D006084:Graft Rejection; D006801:Humans; D016879:Salvage Therapy / Q000379:methods; D014019:Tissue Donors; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D014740:Vidarabine; C024352:fludarabine